Gene · 58484
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disease-associated metabolic pathways affected by heavy metals and metalloid. | Toxicol Rep | 2023 | 37396849 | PubTator, text mining | PubMed |
| Construction and Identification of an NLR-Associated Prognostic Signature Revealing the Heterogeneous Immune Response in Skin Cutaneous Melanoma. | Clin Cosmet Investig Dermatol | 2023 | 37396711 | PubTator, text mining | PubMed |
| Free interleukin-18 is elevated in CD22 CAR T-cell-associated hemophagocytic lymphohistiocytosis-like toxicities. | Blood Adv | 2023 | 37389815 | PubTator, text mining | PubMed |
| Treatment mechanism of immune triad from the repurposing drug against COVID-19. | Transl Med Aging | 2023 | 37388715 | PubTator, text mining | PubMed |
| Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by comprehensive bioinformatics analysis and molecular docking. | BMC Musculoskelet Disord | 2023 | 37386410 | PubTator, text mining | PubMed |
| Identification of D359-0396 as a novel inhibitor of the activation of NLRP3 inflammasome. | Neurochem Int | 2023 | 37385448 | PubTator, text mining | PubMed |
| NEAT1 enhances MPP+ -induced pyroptosis in a cell model of Parkinson's disease via targeting miR-5047/YAF2 signaling. | Immun Inflamm Dis | 2023 | 37382256 | PubTator, text mining | PubMed |
| An engineered xCas12i with high activity, high specificity, and broad PAM range. | Protein Cell | 2023 | 37378659 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases. | Biomol Ther (Seoul) | 2023 | 37376952 | PubTator, text mining | PubMed |
| Roles and Mechanisms of NLRP3 in Influenza Viral Infection. | Viruses | 2023 | 37376638 | PubTator, text mining | PubMed |
| Inflammatory Mediators of Endothelial Dysfunction. | Life (Basel) | 2023 | 37374202 | PubTator, text mining | PubMed |
| The Role of Inflammation in CKD. | Cells | 2023 | 37371050 | PubTator, text mining | PubMed |
| The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. | Cancers (Basel) | 2023 | 37370720 | PubTator, text mining | PubMed |
| Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review. | Metabolites | 2023 | 37367886 | PubTator, text mining | PubMed |
| NOD1 mediates interleukin-18 processing in epithelial cells responding to Helicobacter pylori infection in mice. | Nat Commun | 2023 | 37365163 | PubTator, text mining | PubMed |
| [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes]. | Zhonghua Gan Zang Bing Za Zhi | 2023 | 37365028 | PubTator, text mining | PubMed |
| Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases. | J Allergy Clin Immunol | 2023 | 37364720 | PubTator, text mining | PubMed |
| Inhibition of AIM2 inflammasome activation by SOX/ORF37 promotes lytic replication of Kaposi's sarcoma-associated herpesvirus. | Proc Natl Acad Sci U S A | 2023 | 37364111 | PubTator, text mining | PubMed |
| Genetic fine-mapping from summary data using a nonlocal prior improves the detection of multiple causal variants. | Bioinformatics | 2023 | 37348543 | PubTator, text mining | PubMed |
Inflammasome activation and metabolic remodelling in p16-positive aging cells aggravates high-fat diet-induced lung fibrosis by inhibiting NEDD4L-mediated K48-polyubiquitin-dependent degradation of SGK1. | Clin Transl Med | 2023 | 37345264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58484/papers?page=24